Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1

scientific article published on 01 March 2007

Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.METABOL.2006.10.010
P698PubMed publication ID17292717

P2093author name stringDominique Bonnefont-Rousselot
Claudine Cosson
Jean-Louis Beaudeux
Alain Legrand
Jacqueline Peynet
Nadjat Ouslimani
Meriem Mahrouf
P2860cites workActivation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen speciesQ44987425
P433issue3
P921main subjectmetforminQ19484
P304page(s)308-313
P577publication date2007-03-01
P1433published inMetabolismQ15764354
P1476titleMetformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1
P478volume56

Reverse relations

cites work (P2860)
Q64258986A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function
Q51747235AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.
Q26774333Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
Q33611742Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice
Q42014552Beneficial Effects of Teucrium polium and Metformin on Diabetes-Induced Memory Impairments and Brain Tissue Oxidative Damage in Rats.
Q38831558Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
Q42363364Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
Q46926316Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects
Q34987953Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study
Q34079451LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.
Q54384581Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein.
Q34919719Metformin restores endothelial function in aorta of diabetic rats
Q35475499The discovery of LOX-1, its ligands and clinical significance

Search more.